UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June~~September 30, 2023

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from ____________ to ____________

Commission file number: ~~333~~000-~~226801~~56445

TEO Foods Inc.

(Exact name of small business issuer as specified in its charter)

Nevada	47-1209532
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

Blvd. Insurgentes 19801 unit. 4B

Tijuana, BC. 22225

(Address of principal executive offices)

(619) 758-1973

(Registrants telephone number, including area code)

_____________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Securities registered pursuant to Section 12(b) of the Act: None.

Indicate by check mark whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company; See the definitions of “large accelerated filer”, “accelerated filer”, “non-accelerated filer”, “smaller reporting company” or “emerging growth company” in Rule 12b-2 of the Exchange Act.

☐

large accelerated filer

☐

accelerated filer

☐

Non-accelerated filer

☒

smaller reporting company

☐

emerging growth

company

If an emerging growth company, indicate by check mark if the registrant has elected not to extend the transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~August~~December 2128, 2023, there were 13,071,957 shares of the registrant’s common stock outstanding.

Contents

		Page
		Number
PART I	FINANCIAL INFORMATION	3
Item 1	Interim Consolidated Financial Statements ~~June~~September 30, 2023	3
	Consolidated Balance Sheets	3
	Consolidated Statements of Operations and Comprehensive (Loss) Income	4
	Consolidated Statements of Cash Flows	5
	Consolidated Statements of Stockholders’ Deficit	6
	Notes to the Interim Consolidated Financial Statements	7-14
Item 2	Management's Discussion and Analysis of Financial Condition and Results of Operations	15-18
Item 3	Quantitative and Qualitative Disclosures About Market Risk	18
Item 4	Controls and Procedures	19
PART II	OTHER INFORMATION	20
Item 1	Legal Proceedings	20
Item1A	Risk Factors	20
Item 2	Unregistered Sales of Equity Securities and Use of Proceeds	20
Item 3	Defaults Upon Senior Securities	20
Item 4	Mine Safety Disclosures	20
Item 5	Other Information	20
Item 6	Exhibits	20
SIGNATURES		21

PART I - FINANCIAL INFORMATION

Item 1 - Interim Consolidated Financial Statements ~~June~~ September 30, 2023

TEO Foods, Inc.

CONSOLIDATED BALANCE SHEETS

	March 31, 2023			December 31, 2022
	September 30, 2023			December 31, 2022
		(Unaudited)
Assets
Current assets
Cash and cash equivalents	$	21,~~483~~371		$	657
Accounts receivable, net		1430,~~829~~971			25,924
Inventories, net		—			—
Taxes receivable, net		4042,~~386~~935			37,563
Prepaid and other assets		13,302			13,303
Total current assets		7188,~~000~~579			77,447
Property and equipment, net		2522,~~067~~448			30,278
Total assets	$	96111,~~067~~027		$	107,725
Liabilities and stockholders' (deficit)
Current liabilities
Accounts payable and accrued expenses	$	~~450~~481,~~447~~269		$	370,072
Related party advances		~~188~~231,~~205~~005			130,100
License fee payable - related party		629,833			629,833
Notes payable		100,000			100,000
Convertible note payable		345,500			345,500
Total current liabilities		1,~~713~~787,~~985~~607			1,575,505
Total liabilities		1,~~713~~787,~~985~~607			1,575,505
Commitments and contingencies (Note 14)		—			—
Stockholders' deficit
Preferred stock, $0.001 par value, 10,000,000 shares authorized, 9,022,900 shares issued and outstanding		9,023			9,023
Common stock, $0.001 par value, 490,000,000 shares authorized, 13,071,957 and 13,071,957 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively		13,072			13,072
Common stock, $0.001 par value, 490,000,000 shares authorized, 13,071,957 and 13,071,957 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively		13,072			13,072
Additional paid-in capital		1,176,635			1,176,635
Accumulated deficit		(2,~~826~~885,~~523~~515	)		(2,661,744	)
Other comprehensive income (loss)		910,~~875~~205			(4,766	)
Total stockholders' deficit		(1,~~617~~676,~~918~~580	)		(1,467,780	)
Total liabilities and stockholders' deficit	$	96111,~~067~~027		$	107,725

The accompanying notes are an integral part of these consolidated financial statements.

TEO Foods, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

	For the Three Months Ended						For the ~~Six~~Nine Months Ended
	June 30,						June 30,
	September 30,						September 30,
	2023			2022			2023			2022
Sales	$	3629,~~021~~523		$	1049,~~519~~516		$	6998,~~286~~809		$	1060,~~519~~035
Cost of sales		—			—			—			—
Gross profit		3629,~~021~~523			1049,~~519~~516			6998,~~286~~809			1060,~~519~~035
Operating expense
Payroll		—			71,~~440~~148			—			1617,~~816~~964
General and administrative		1110,~~080~~346			410,~~426~~665			1930,~~915~~261			1222,~~207~~862
Rent and lease		4943,~~772~~696			4238,~~423~~390			94138,~~870~~566			79117,~~325~~715
Professional fees		3618,~~576~~676			5040,~~207~~076			~~101~~120,~~665~~341			82122,~~364~~440
Depreciation		2,~~619~~620			2,~~619~~648			57,~~210~~830			57,~~210~~858
Total operating expenses		~~100~~75,~~047~~338			~~107~~92,~~115~~917			~~221~~296,~~660~~998			~~195~~288,~~922~~839
Operating loss		(6445,~~026~~815	)		(9643,~~596~~401	)		(~~152~~198,~~374~~189	)		(~~185~~228,~~403~~804	)
Other income (expense)
Licensing and royalty income		—			—			—			6,787
Loss on Royalty Agreement		—			~~(31,929~~—			—			(31,929	)
Other income (expense)		4(3,~~007~~429	)		2(13,~~413~~465	)		73,~~086~~657			1(11,~~946~~519	)
Interest expense		(9,~~754~~748	)		(9,~~495~~566	)		(1929,~~490~~238	)		(1828,~~846~~412	)
Total other (loss) income		(513,~~747~~177	)		(3923,~~011~~031	)		(1225,~~404~~581	)		(4265,~~042~~073	)
Net (loss) income before income taxes		(6958,~~773~~992	)		(~~135~~66,~~607~~432	)		(~~164~~223,~~778~~770	)		(~~227~~293,~~445~~877	)
Income tax expense		—			—			—			—
Net (loss) income		(6958,~~773~~992	)		(~~135~~69,~~607~~432	)		(~~164~~223,~~778~~770	)		(~~227~~293,~~445~~877	)
Other comprehensive (loss) income
Foreign currency transaction adjustment		~~11,949~~330			~~3,044~~76			910,~~875~~205			(~~853~~777	)
Comprehensive income (loss)	$	(5758,~~825~~662	)	$	(~~138~~66,~~651~~356	)	$	(~~154~~213,~~903~~565	)	$	(~~228~~294,~~298~~654	)
Earnings (loss) per common share -
Basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.0102	)	$	(0.02	)
Weighted average common
shares outstanding – basic and diluted		13,071,957			13,071,957			13,071,957			13,~~071~~046,957

The accompanying notes are an integral part of these consolidated financial statements.

TEO Foods Inc.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Six Months Ended June 30,
	For the Nine Months Ended September 30,
	2023			2022
Net loss	$	(~~164~~223,~~779~~770	)	$	(~~227~~293,~~445~~877	)
Adjustments to reconcile net loss to net Cash used in operations:
Depreciation expense		57,~~211~~830			57,~~210~~858
Loss on Royalty Agreement		—			31,929
Bad debt		—			6,037
Changes in operating assets and liabilities:
Accounts receivable		(115,~~095~~047	)		(425,~~082~~606	)
Licensing and royalty income receivable		—			6,097
Inventories		—			(41	)
Tax receivables		(25,~~823~~372	)		(~~7468~~8,197	)
Prepaid and other assets		—			43(97	)
Accounts payable and accrued expenses		80111,~~375~~197			~~100~~136,~~177~~275
Net cash (used) in operating activities		(70115,~~921~~162	)		(95139,~~580~~622	)
Cash flows from investing activities
Purchase of property and equipment		—			—
Net cash (used) in investing activities		—			—
Cash flows from financing activities
Proceeds from related party advances		58100,~~105~~905			64111,~~400~~221
Proceeds from issuance of promissory notes		—			6,000
Proceeds from issuance of common stock		—			20,000
Payment of deemed dividend to Teo Inc. for license		—			(1,~~300~~700	)
Net cash provided by (used) in financing activities		58100,~~105~~905			89135,~~100~~521
Effect of foreign currency exchange translation		14,~~641~~971			(~~853~~777	)
Net change for period		~~1,825~~714			(74,~~333~~878	)
Cash and Cash Equivalents at beginning of period		657			7,555
Cash and Cash Equivalents at end of period	$	21,~~482~~371		$	~~222~~2,677
Supplement Information:
Cash paid for:
Interest	$	—		$	—
Income taxes	$	—		$	—

The accompanying notes are an integral part of these consolidated financial statements.

TEO Foods, Inc.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited)

	Preferred Stock				Common Stock				Additional Paid-in		Accumulated			Other Comprehensive
	Shares		Amount		Shares		Amount		Capital		Deficit			Income(loss)			Total
Three months ended June 30, 2022
Nine months ended September 30, 2022
Balance - December 31, 2021		9,022,900	$	9,023		12,971,957	$	12,972	$	1,156,735	$	(2,314,436	)	$	(197	)	$	(1,135,903	)
Stock issued for cash		—		—		100,000		100		19,900		—			—			20,000
Foreign currency translation adjustments		—		—		—		—		—		—			2,191			2,191
Net (loss) income		—		—		—		—		—		(91,838	)		—			(91,838	)
Balance March 31, 2022		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,406,274	)	$	1,994		$	(1,205,550	)
Foreign currency translation adjustments		—		—		—		—		—		—			(3,044	)		(3,044	)
Net (loss) income		—		—		—		—		—		(135,607	)		—			(135,607	)
Balance June 30, 2022		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,541,881	)	$	(1,050	)	$	(1,344,201	)
Three months ended June 30, 2023
Foreign currency translation adjustments		—		—		—		—		—		—			76			76
Net (loss) income		—		—		—		—		—		(66,432	)		—			(66,432	)
Balance September 30, 2022		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,608,313	)	$	(974	)	$	(1,410,557	)
Nine months ended September 30, 2023
Balance - December 31, 2022		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,661,745	)	$	4,766		$	(1,467,780	)
Foreign currency translation adjustments		—		—		—		—		—		—			(2,074	)		(2,074	)
Net (loss) income		—		—		—		—		—		(95,005	)		—			(95,005	)
Balance March 31, 2023		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,756,750	)	$	2,692		$	(1,564,859	)
Foreign currency translation adjustments		—		—		—		—		—		—			916,~~875~~716			916,~~875~~716
Net (loss) income		—		—		—		—		—		(~~164~~69,~~799~~774	)		—			(~~164~~69,~~799~~774	)
Balance June 30, 2023		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,~~922~~826,~~049~~524	)	$	1219,~~567~~408		$	(1,617,918	)
Foreign currency translation adjustments		—		—		—		—		—		—			330			330
Net (loss) income		—		—		—		—		—		(58,992	)		—			(58,992	)
Balance September 30, 2023		9,022,900	$	9,023		13,071,957	$	13,072	$	1,176,635	$	(2,885,516	)	$	19,738		$	(1,676,580	)

The accompanying notes are an integral part of these consolidated financial statements.

TEO Foods Inc.

NOTES TO THE INTERIM CONSOLIDATED FINANCIAL STATEMENTS

~~June~~September 30, 2023

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION

TEO Foods Inc. (“Company”) was incorporated in the state of Nevada on December 27, 2012.

The Company’s principal activity is to produce and sell food packaged products for retail sale in the frozen, refrigerated and shelf stable categories. The Company has a license to use the TEO name and logo on food products it sells and to apply the TEO pasteurization/sterilization processes to its products for improved shelf life and safety.

In January 2020, the Company created BCTEO Foods S.A. de C.V. (“BC TEO Foods”), a 100% owned subsidiary in Mexico. BCTEO Foods is the operating entity in Mexico and holds all facilities leases.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Consolidation

The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the ~~Six~~Nine months ended ~~June~~September 30, 2023 are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. Notes to the unaudited consolidated financial statements that would substantially duplicate the disclosure ~~contained~~ contained in the audited consolidated financial statements for the fiscal year ending December 31, 2023 have been omitted. The Company ~~consolidates~~ consolidates the financial statements of its wholly-owned subsidiaries and all intercompany transactions and account balances have been ~~eliminated~~ eliminated in consolidation.

All amounts referred to in the notes to the consolidated financial statements are in United States Dollars ($) unless stated otherwise.

Cash and Cash Equivalents

The Company considers all highly liquid debt instruments and other short-term investments with a maturity date of three months or less, when purchased, to be cash equivalents.

Foreign Currency Translation

The Company subsidiary’s primary functional currency is the Mexican peso, but it’s reporting currency is the U.S. dollar. The balance sheet accounts are translated at exchange rates in effect at the end of the period and income statement accounts are translated at average exchange rates for the period. Translation gains and losses are included as a separate component of stockholders’ deficit.

Accounts Receivable

Accounts receivable are reported at the customers’ outstanding balances less any allowance for doubtful accounts. Interest is not accrued on overdue accounts receivable. The allowance for doubtful accounts at ~~June~~September 30, 2023 and December 31, 2022 was $0.

Inventory and Cost of Sales

Inventories are stated at the lower of cost or realizable value, using the average cost method. When an impairment indicator suggests that the carrying amounts of inventories might not be recoverable, the Company reviews such carrying amounts and estimates the net realizable value based on the most reliable evidence available at that time. An impairment loss is recorded if the net realizable value is less than the carrying value. Impairment indicators considered for these purposes are, among others, obsolescence, decrease in market prices, damage and a firm commitment to sell.

Property and Equipment

Property and equipment are stated at cost. Major renewals and improvements are charged to the asset accounts while replacements, maintenance and repairs that do not improve or extend the lives of the respective assets are expensed. At the time property and equipment are retired or otherwise disposed of, the asset and related accumulated depreciation accounts are relieved of the applicable amounts. Gains or losses from retirements or sales are credited or charged to income.

Impairment of Long-Lived and Intangible Assets

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the book value of the asset may not be recoverable. The Company periodically evaluates whether events and circumstances have occurred that indicate possible impairment. When impairment indicators exist, the Company uses market quotes, if available, or an estimate of the future undiscounted net cash flows of the related asset or asset group over the remaining life in measuring whether or not the asset values are recoverable. The Company did not recognize impairment on its long-lived assets during the periods ended ~~March~~September 3130, 2023 or 2022. Identified intangible assets are reviewed for impairment at least annually, or whenever ~~events~~ events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company’s only intangible asset ~~consists~~ consists of the royalty agreement discussed in Note 7.

Convertible Debentures

The Company adopted the guidance in Accounting Standards Updated (“ASU”) 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity on January 1, 2022. ASU 2020-06 simplifies an issuer’s accounting for convertible instruments and its application of the derivatives scope exception for contracts in its own equity. Additionally, ASU 2020-06 removes the requirements for accounting for beneficial conversion features. The Company adopted ASU 2020-06 utilizing the modified retrospective method, which resulted in an immaterial impact to the Company.

Revenue Recognition

The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, “Revenue from Contracts with Customers” (“Topic 606”). Revenue is recognized when a customer obtains control of promised goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The amount of revenue that is recorded reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five-step model in order to determine this amount:

	i.	Identification of the promised goods in the contract;
	ii.	Determination of whether the promised goods are performance obligations, including whether they are distinct in the context of the contract;

	iii.	Measurement of the transaction price, including the constraint of variable consideration;
	iv.	Allocation of the transaction price of the performance obligations; and
	v.	Recognition of revenue when (or as) the Company satisfies each performance obligation.

The Company only applies the five-step model to contracts when it is probable the entity will collect the consideration it is entitled to in exchange for the goods and services it transfers to the customer. Once a contract is determined to be within the scope of Topic 606 at contract inception, the Company reviews the contract to determine which performance obligations the Company must deliver and which of these performance obligations are distinct. The Company recognizes as revenues the amount of the transaction price that is allocated to the respective performance obligations when the performance obligation is satisfied or as it is satisfied. Generally, the Company’s performance obligations are transferred to customers at a point in time typically upon delivery. The Company primarily sells packaged food products to its customers. The Company’s performance obligation is satisfied when the goods have been delivered, which is at a point in time. The Company provides manufacturing services for packaged food and other products. The Company’s performance obligation is satisfied for services when the services are completed or the related products have been delivered, which is at a point in time. The Company receives revenue from a licensing and royalty agreement and the licensee incurs fees based on their sales to their customers, which occurs when the products are delivered. The Company’s performance obligation related to these agreements is satisfied at the point in time when the products are delivered.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

Fair Value of Financial Instruments

Fair value is defined as the price that would be received in the sale of an asset or that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company has categorized all investments recorded at fair value based upon the level of judgment associated with the inputs used to measure their fair value.

Hierarchical levels, directly related to the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:

●

Level 1: Quoted prices in active markets for identical assets or liabilities that the organization has the ability to access at the reporting date.

●

Level 2: Inputs other than quoted prices included in Level 1, which are either observable or that can be derived from or corroborated by observable data as of the reporting date.

●

Level 3: Inputs include those that are significant to the fair value of the asset or liability and are generally less observable from objective resources and reflect the reporting entity's assumptions about the assumptions market participants would use in pricing the asset or liability.

The Company's financial instruments consist of advances from related party, notes payable, convertible notes payable and license fee payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of the respective instruments.

Loss Per Share of Common Stock

Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding for the period. The calculation of diluted earnings (loss) per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Securities with anti-dilutive effects on net earnings (loss) per share are excluded. As of June 30, 2023 and 2022, none of the convertible preferred shares or convertible debt were included in the calculation of diluted weighted average shares as they were anti-dilutive.

As of ~~June~~September 30, 2023 and 2022, preferred shares ~~convertible~~ convertible to 90,229,000 common shares were included in the diluted weighted average shares; however, notes convertible into a maximum of 1,727,500 ~~and~~ ~~1,697,500~~ common shares were excluded from the calculation of loss per common share as the notes are anti-dilutive. As of ~~June~~ September 30, 2023 and 2022, common shares outstanding totaled 13,071,957.

NOTE 3 – GOING CONCERN

These consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has suffered recurring losses from operations and has insufficient working capital as of ~~June~~ September 30, 2023 to develop its business plan and meet its obligation of the next 12 months. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial ~~support~~ support from its stockholders, the Company's ability to obtain necessary equity or debt financing to continue operations, and ultimately the Company's ability to generate profit from sales of packaged food products. These consolidated financial statements do not include any adjustments to classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company plans to obtain funds for operations through continued financial support from its stockholders, debt and private offerings of its equity.

NOTE 4 – INVENTORY

Inventory consists of raw materials and finished goods located in the Company’s warehouse in Tijuana, Mexico. At ~~June~~September 30, 2023 and December 31, 2022, inventories were $0.

NOTE 5 – TAX RECEIVABLES

Tax receivables represent credits from the Mexican taxing authority. The Company’s Mexican subsidiaries have accumulated IVA tax payments that exceeded its IVA tax liabilities. The Company periodically applies for refunds of these accumulated overpayments. These overpayments are also available to the Company to offset future IVA liabilities. The tax receivable balance at ~~June~~September 30, 2023 and December 31, 2022 was $4042,~~386~~935 and $37,563, respectively.

NOTE 6 – PROPERTY AND EQUIPMENT

At ~~June~~September 30, 2023 and December 31, 2022, property ~~and~~ and equipment consisted of the following:

Schedule of property and equipment
	June 30, 2023			December 31, 2022
	September 30, 2023			December 31, 2022
Machinery and equipment	$	42,502		$	42,502
Transportation equipment		10,032			10,032
		52,534			52,534
Less accumulated depreciation		(2730,~~466~~036	)		(22,256	)
	$	2522,~~068~~448		$	30,278

Depreciation expense for the three months ended ~~June~~September 30, 2023 and 2022 was $2,619 and $2,~~591~~648, respectively. The estimated useful lives of fixed assets is 5 years.

NOTE 7 – ROYALTY AND LICENSE AGREEMENT

On September 30, 2017, the Company entered into a Master Agreement with TEO Inc. ("TEO"). TEO is the founder and majority controlling shareholder of the Company. The Master Agreement provides the Company a license to use the TEO name and logo on food products it sells and to apply TEO's pasteurization/sterilization processes to its products for improved shelf life and safety. Additional provisions provide the Company production rights to TEO's pasteurizer/sterilizer and rights to lease its own system when certain sales/production increase. Pursuant to the master agreement, the Company agreed to pay an initial $1 million fee in installments with $100,000 due on June 30, 2018, $300,000 due on December 31, 2018 and the remaining $600,000 due in 12 equal monthly payments with the first payment due on January 31, 2019. TEO Inc. has agreed to maintain the license through December 31, 2023 and accrue and accept payments due as funds are available. TEO Inc. has agreed to extend the start date to January 1, 2024 of the use/royalty and service fee of 5.5% of the Company's gross revenue for food sales processed using TEO's intellectual property. The ongoing licensing is maintained by meeting minimum annual use/royalty and service fees. The Company may pay for the difference between the actual use and the minimum to maintain the license. The annual minimum is listed as follows:

Schedule of Royalty and License Agreements
Schedule of royalty and license agreements
Year	Minimum Service Fee
2024	$	500,000
2025		750,000
2026		1,000,000
Thereafter		Increase 10% per year

As a result of TEO being the majority shareholder of the Company and TEO's basis in the license being $0, the Company recorded a deemed dividend of $1 million for the initial fee payable to TEO. As of ~~June~~September 30, 2023 and December 31, 2022, the outstanding balance of the license fee payable was $629,833. For the ~~six months~~nine months ended ~~June~~September 30, 2023 and 2022, the Company made payments toward the license of $0 and $1,~~300~~700, respectively.

Effective April 1, 2020, the Company entered into an agreement whereby it assigned half and licensed half of the Nerys Brand for cheese products in Mexico, along with certain production equipment and facilities that the Company did not intend to transfer to its new facility for production, to a third party. In exchange, the Company receives a portion of net revenue from all products sold, which includes bulk meats and other products, by the acquirer, a royalty on all NERYS cheese products sold in Mexico of $0.01 per pound and will also receive five percent of the proceeds of any sale of the related acquirer’s business.

The Company valued the royalty agreement at the book value of the assets transferred of $31,929, which approximates the fair value and is recorded as an intangible asset on the consolidated balance sheets as of December 31, 2021.

On June 7, 2022, the facility used by the licensee was destroyed in a fire. The licensee has informed the Company that its insurance will not pay the loss and as a result is closing all of its business operations. Pursuant to the agreement all rights to the NERYS cheese products sold in Mexico revert back to the Company and it is evaluating the economic viability of resuming fulfillment of the retail placements in Mexico.

As a result, during the year ended December 31, 2022, the Company has written off the value of the royalty agreement totaling $31,929, which is included within other income (expense) on the consolidated statements of operations and comprehensive loss.

In May 2022, the Company licensed the Nerys Brand for products sold outside Mexico to an international distributor of a variety of meat, fish, cheese and other food products throughout the USA, south and central America. In exchange it will receive a royalty on the NERYS branded products sold outside of Mexico and will be the supplier of these branded products.

NOTE 8 – NOTES PAYABLE

Notes Payable

On July 31, 2018, the Company issued a note for $100,000 in principal bearing interest at 8% maturing on October 31, 2018. This note was subsequently amended to extend the maturity date to December 31, 2022. As of ~~June~~September 30, 2023, and December 31, 2022, the outstanding principal balance of the note was $100,000.

Convertible Note Payable

On June 28, 2018, the Company issued a note for $100,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. The maturity date of the note is December 31, 2023.

On February 4, 2019, the Company issued a note for $120,000. The note can be converted to common stock at $0.20 per share or the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share and converts automatically upon certain conditions. The note bears no interest until September 30, 2019 and then bears 8% interest, if not converted to common stock. This note was subsequently amended to extend the maturity date to December 31, 2023. On December 20, 2020, the holder converted $27,500 in principal of this note to 137,500 common shares at $0.20 per share.

On May 5, 2021, the Company issued a note for $25,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

On June 1, 2021, the Company issued a note for $20,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023. On December 20, 2021, the holder converted $10,000 in principal of this note to 50,000 common shares at $0.20 per share.

On June 2, 2021, the Company issued a note for $17,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

On July 12, 2021, the Company issued a note for $40,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

On September 29, 2021, the Company issued a note for $15,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

On November 24, 2021, the Company issued a note for $40,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

On April 14, 2022, the Company issued a note for $6,000. The note bears an 8% interest rate, due at maturity. The note is convertible into common shares at a 20% discount to the 30-day average bid price of the Company's common shares, as may be quoted on the OTCQB, OTCQX or listing on a national stock exchange, but at no rate lower than $0.20 per share. This note was subsequently amended to extend the maturity date to December 31, 2023.

The principal balance of convertible debt at ~~June~~September 30, 2023 and December 31, 2022 amounted to $345,500.

NOTE 9 – EQUITY

Preferred Stock

Each share of Class A Preferred Stock may be converted by the holder upon request of the holder into 10 shares of common stock. Each holder is entitled to 100 votes for each share of Class A Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Company for their action or consideration. The holders are entitled to dividends, if any, as declared by the Company and participate pari passu with the common stock of the Company at the conversion rate.

NOTE 1110 - INCOME TAXES

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The U.S. federal income tax rate is 21%.

The provision for Federal income tax consists of the following ~~June~~September 30, 2023 and 2022:

Schedule of provision for income tax
Federal income tax (expense) benefit attributable to:	~~June~~September 30, 2023			~~June~~September 30, 2022
Current Operations	$	3141,~~998~~620		$	4861,~~357~~887
Less: valuation allowance		(3141,~~998~~620	)		(4861,~~357~~887	)
Net provision for Federal income taxes	$	—		$	—

The cumulative tax effect at the expected rate of 21% of significant items comprising our net deferred tax amount is as follows:

Schedule of deferred tax asset
Deferred tax asset attributable to:	~~June~~September 30, 2023			December 31, 2022
Net operating loss carryover	$	~~152~~198,~~374~~189		$	313,455
Less: valuation allowance		(~~152~~198,~~374~~189	)		(313,455	)
Net deferred tax asset	$	—		$	—

At ~~June~~September 30, 2023, the Company had net operating ~~loss~~ loss carry forwards of approximately $1,~~528~~573,000 that may be offset against future taxable income. No tax benefit has been reported in the ~~June~~ September 30, 2023 or December 31, 2022 consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.

Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

ASC 740 provides guidance on the accounting for uncertainty in income taxes recognized in a company’s financial statements. ASC 740 requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more-likely-than- not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements.

The Company includes interest and penalties arising from the underpayment of income taxes in the consolidated statements of operations in the provision for income taxes. As of ~~June~~ September 30, 2023 and 2022, the Company had no accrued interest or penalties related to uncertain tax positions.

NOTE 11 - RELATED PARTY TRANSACTIONS

The Company has various related party receivables and payables derived from normal operating activities. These balances are non-interest bearing and are periodically settled as cash flow permits. These payables may include accrued compensation to officers. Accrued fees for services owed to the CEO as of ~~June~~September 30, 2023 ~~and~~ and December 31, 2022 was $~~257~~272,600 and $211,100, respectively, and are included within accounts payable and accrued expenses on the consolidated balance sheets. Cash advances made by the CEO as of ~~June~~September 30, 2023 and December 31, 2022 was $~~188~~231,~~204~~005 and $130,100, respectively.

Master License Agreement

On September 30, 2017, the Company entered into a Master Agreement with TEO, the founder and majority controlling shareholder of the Company. See Note 7.

NOTE 12 – COMMITMENTS AND CONTINGENCIES

During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with Financial Accounting Standards Board Accounting Standards Codification “FASB ASC” 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of ~~March~~September 3130, 2023 and December 31, 2022, the Company is not aware of any contingent liabilities that should be reflected in the ~~financial~~ financial statements.

At ~~March~~September 3130, 2023, the Company had three leases on on commercial units that are contiguous in the same building located in Tijuana Mexico and comprising approximately 38,000 square feet total. The leases are 12 month leases with option to renew for additional 12 month periods. The total rents are approximately $16,000 per month gross with no additional common fees or other charges. The Company paid a total of $94138,~~870~~566 and $79117,~~325~~715 during the ~~six~~nine month period ended ~~June~~ 31September 30, 2023 and 2022, respectively, related to the leases of commercial units in Tijuana. The leases are short term in nature as the Company is not certain to renew the leases.

NOTE 13 – CONCENTRATIONS

Cash Deposit

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits. At ~~June~~September 30, 2023 and December 31, 2022, no cash balances exceeded the federally insured limit.

NOTE 14 - SUBSEQUENT EVENTS

The Company has evaluated subsequent events for recognition and disclosure through ~~August~~December 2128, 2023 which is the date the consolidated financial statements were available to be issued. No other ~~matters~~ matters were identified affecting the accompanying consolidated financial statements and related disclosures.

Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations

The following Management's Discussion and Analysis should be read in conjunction with our consolidated financial statements and the related notes thereto. The Management's Discussion and Analysis may contain “forward-looking statements.” Any statements that are not statements of historical fact are forward-looking statements.

These statements are based on the current expectations, forecasts, and assumptions of our management and are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by the forward-looking statements. Forward-looking statements are sometimes identified by language such as “believes,” “anticipates,” “estimates,” “expects,” “plans,” “intends,” “projects,” “future” and similar expressions and may also include references to plans, strategies, objectives, and anticipated future performance as well as other statements that are not strictly historical in nature.

The risks, uncertainties, and other factors that could cause our actual results to differ materially from those expressed or implied in this Quarterly Report on Form 10-Q include:

	●	our ability to successfully develop and sell our products;
	●	our ability to obtain additional financing at favorable rates to maintain and develop our operations;
	●	competitive conditions in our industry; and
	●	the ability to attract and retain key personnel.

There may be other factors that may cause our actual results to differ materially from the forward-looking statements. We can give no assurances that any of the events anticipated by the forward-looking statements will occur or, if any of them do, what impact they will have on our results of operations and financial condition. Readers should carefully consider this information as well as the risks and other uncertainties described in our other filings made with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements. They reflect opinions, assumptions, and estimates only as of the date they were made, and we undertake no obligation to publicly update or revise any forward-looking statements in this Quarterly Report on Form 10-Q, whether as a result of new information, future events or circumstances, or otherwise.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We have identified the following accounting policies that we believe are key to an understanding of our financial statements. These are important accounting policies that require management's most difficult, subjective judgments.

Foreign Currency Translation

Convertible Debentures

Overview

TEO Foods Inc. (“Company”) was incorporated in the state of Nevada on December 27, 2012.

In January 2020, the Company created BCTEO Foods S.A. de C.V. (“BC TEO Foods”), a 100% owned subsidiary in Mexico. BCTEO Foods is the operating entity in Mexico and holds all facilities leases.

In March 2022, we received initial licensing in Mexico to produce alcohol in our Tijuana facilities. We are currently able to produce and export alcoholic beverages produced in our facility. We are in the process of completing licensing that will allow us to distribute and sell throughout Mexico. We believe that the addition of alcoholic and non-alcoholic beverages to our capabilities will expand our opportunities in the USA and Mexico.

In May 2022, we licensed the Nerys Brand for products sold outside Mexico to an international distributor of a variety of meat, fish, cheese and other food products throughout the USA, south and central America. In exchange we will receive a royalty on the NERYS branded products sold outside of Mexico and will be the supplier of these branded products.

In January 2020, the Company created BCTEO Foods S.A. de C.V. (“BC TEO Foods”), a 100% owned subsidiary in Mexico. BCTEO Foods is the operating entity in Mexico and holds all facilities leases.

We will continue to develop our products and services. We will continue to pursue co-packing opportunities to support production planning, formulation, equipment acquisition, testing, validation, branding and sales of new products. This assumes that we are able to secure additional capital to purchase the necessary equipment, supplies (trays, film, carton/print materials, etc.), retain consultants/staff and provide for other costs of production.

We have received equity and debt investments both from insiders and from private investors. As we expand operational activities, we may continue to experience operating losses and/or negative cash flows from operations and may be required to obtain additional financing to fund operations. There can be no assurance that we will be able obtain additional financing, if at all, or upon terms that will be acceptable to us.

Our prospects must be considered in light of the risks, expenses and difficulties frequently encountered by companies in our stage of development. Such risks include, but are not limited to, an evolving business model and the management of growth.

To address these risks we must, among other things, implement and successfully execute our business and marketing strategy and attract, retain and motivate qualified personnel. There can be no assurance that we will be successful in addressing such risks, and the failure to do so can have a material adverse effect on our business prospects, financial condition and results of operations.

Results of Operations

Results of Operations for the Three Months Ended ~~June~~September 30, 2023 and 2022

During the three-month periods ended ~~June~~September 30, ~~2023~~ 2023 and 2022, the Company had $3629,~~021~~523 and $1049,~~519~~516 in sales revenue, respectively. During the three-month periods ended ~~June~~September 30, 2023 and 2022, the Company had $0 and $0 in licensing and royalty revenue, respectively.

~~The~~Revenue ~~increase~~is ~~was due to new revenue~~ from warehousing and logistics services utilizing our cold and dry storage.

The licensing and royalty revenue for Mexico terminated during the second quarter of 2022 due to a fire in the licensee’s facility, we were notified that they have discontinued operations. We are focusing on establishing ~~distribution~~warehousing ~~relationships~~ and ~~providing~~distribution ~~our own products through those channels~~relationships. ~~We are also seeking co-packing opportunities.~~

During the three-month periods ended ~~June~~September 30, ~~2023~~ 2023 and 2022, we had general and administrative expenses of $1110,~~080~~346 and $410,~~426~~665, respectively. Payroll expenses were $0 and $71,~~440~~148 during ~~the~~ the three-month periods ended ~~June~~September 30, 2023 and 2022, respectively. Payroll decreased due to using contractors. These expenses are ~~expected~~ expected to increase as we add production staff for operations. Rent and lease expenses were $4943,~~772~~969 and $4238,~~423~~390 for the three-month periods ~~ended~~ ~~June~~ended September 30, 2023 and 2022, respectively. Rent and lease expenses increased as a result of a rate increase. Depreciation expenses were $2,~~619~~ 620 and $2,~~619~~648 for the three-month period ended ~~June~~September 30, 2023 and 2022, respectively. Professional fees were $3618,~~576~~676 and $5040,~~207~~076 for the three-month periods ended ~~June~~September 30, 2023 and 2022, respectively. The increase was partially due to fees paid related to obtaining quotation on the OTCQB.

~~Interest expense was $9,754 and $9,495 for the three-month periods ended June 30, 2023 and 2022, respectively. This interest is primarily related to notes payable.~~ s

~~The~~Interest ~~Company's~~expense ~~comprehensive~~was ~~loss~~$9,748 and $9,566 for the three-month periods ended ~~June~~September 30, 2023 and 2022 ~~was $154~~,~~904~~ ~~and $138,651,~~ respectively. ~~The~~This ~~losses~~interest ~~remained~~is ~~consistent~~primarily ~~between~~related ~~the periods due~~ to ~~the~~notes ~~level of operations being consistent~~payable.

~~Results~~The ofCompany's ~~Operations~~comprehensive loss for the three-month ~~Six~~periods ~~Months~~ended ~~Ended June~~September 30, 2023 and 2022 was $58,662 and $66,356, respectively. The losses remained consistent between the periods due to the level of operations being consistent.

~~During~~Results ~~the~~of ~~six-month~~Operations ~~periods~~for ~~ended~~the ~~June~~Nine ~~30,~~Months ~~2023 and~~Ended ~~2022,~~September ~~the Company had $69,286 and $10,519 in sales revenue, respectively. During the six-month periods ended June~~ 30, 2023 and 2022~~, the Company had $0 and $6,787 in licensing and royalty revenue, respectively.~~

During the ~~six~~nine-month periods ended ~~June~~September 30, ~~2023 and~~ ~~2022, we had general and administrative expenses of $19,915 and $12,207, respectively. Payroll expenses were $0 and $16,816 during the six-month periods ended June 30,~~ 2023 and 2022, ~~respectively.~~the ~~Rent~~Company ~~and~~had ~~lease expenses were~~ $9498,~~870~~809 and $7960,~~325~~035 ~~for~~in ~~the~~sales ~~six-month periods ended June 30~~revenue, ~~2023 and 2022,~~ respectively. ~~Depreciation~~During ~~expenses were $5,210 and $5,210 for~~ the ~~six~~nine-month ~~period~~periods ended ~~June~~September 30, 2023 and 2022, ~~respectively.~~the ~~Professional~~Company ~~fees~~had ~~were~~ $~~101,665~~0 and $826,~~364~~787 ~~for~~in ~~the~~licensing ~~six-month~~and ~~periods~~royalty ~~ended June 30~~revenue, ~~2023 and 2022,~~ respectively.

~~Interest~~During ~~expense~~the ~~was~~nine-month periods ended September 30, 2023 and 2022, we had general and administrative expenses of $1930,~~490~~261 and $1822,~~846~~862, respectively. Payroll expenses were $0 and $17,964 during the nine-month periods ended September 30, 2023 and 2022, respectively. Rent and lease expenses were $138,566 and $117,715 for the ~~six~~nine-month periods ended ~~June~~September 30, 2023 and 2022, respectively. ~~This~~Depreciation ~~interest~~expenses iswere ~~primarily~~$7,830 ~~related~~and to$7,858 ~~notes~~for ~~payable~~the nine-month period ended September 30, 2023 and 2022, respectively. Professional fees were $120,341 and $122,440 for the nine-month periods ended September 30, 2023 and 2022, respectively.

Interest expense was $29,238 and $28,412 for the nine-month periods ended September 30, 2023 and 2022, respectively. This interest is primarily related to notes payable.

Expenses are expected to increase as our operations develop and we continue to provide services and introduce new products into the market.

Liquidity and Capital Resources

As of ~~June~~September 30, 2023, we had total assets of $96111,~~067~~027 and total liabilities of $1,~~713~~787,~~985~~607. As of December 31, 2022, we had total assets of $107,725 and total liabilities of $1,575,505. During the ~~three~~nine-month periods ended ~~June~~September 30, 2023 and 2022, the Company paid $0 and $1,~~300~~700, respectively, toward the current portion of ~~the~~ the license fee payable.

Net cash used in investing activities for the ~~six~~nine-month periods ended ~~June~~September 30, 2023 and 2022 was $0 and $0, respectively. Net cash provided from financing activities for the ~~six~~nine-month ~~periods~~ periods ended ~~June~~September 30, 2023 and 2022 was $58100,~~105~~905 and 54135,~~900~~521, respectively. The cash provided was primarily due to loans from our CEO for the ~~six~~nine-month periods ended ~~June~~September 30, 2023 and 2022 of $58100,~~105~~905 and $35111,~~500~~221, respectively.

Net cash used in operating activities for the ~~six~~nine-month periods ended ~~June~~September 30, 2023 and 2022 was $1115,~~647~~162 and $63139,~~167~~622, respectively. A substantial portion of these amounts resulted from ~~accrued~~ accrued salary expense due to our CEO totaling $1545,000 and $3163,~~500~~000, respectively.

Over the next twelve months, we believe that we will require additional capital and anticipated funds from operations to further develop and sustain our operations. The Company will need to seek additional financing to expand operations and create revenue with the introduction of its products to the market. The TEO license requires future payments and royalty payments on related revenue.

We believe that we will need to raise an additional $1,000,000 over the next 12 months and intend to seek additional investment through a private or a public equity offering. We will use the proceeds to cover our product development, auditing and accounting costs, licensing, necessary equipment, supplies (trays, film, carton/print materials, etc.), retain consultants/staff, provide for other costs of production and other working capital needs.

There can be no assurance that we will be able obtain additional financing, if at all or upon terms that will be acceptable to us. There can be no assurance of when, if ever, our operations become profitable.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements or financing activities with special purpose entities.

Going Concern

The Company’s consolidated financial statements have been prepared on a going concern basis, which implies the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has suffered recurring losses from operations and has insufficient working capital as of ~~June~~September 30, 2023. These factors raise substantial doubt regarding the Company's ability to continue as a going concern. The continuation of the Company as a going concern is dependent upon the continued financial support from its stockholders, the Company's ability to obtain necessary equity or debt financing to continue operations, and ultimately the Company's ability to generate profit from sales of packaged food products. These consolidated financial statements do not include any adjustments to classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company plans to obtain fund for operations through continued financial support from its stockholders, debt and private offerings of its equity.

Item 3 - Quantitative and Qualitative Disclosures About Market Risk

Not required for Smaller Reporting Companies.

Item 4 - Controls and Procedures

Evaluation of Disclosure Controls and Procedures

The Company’s Principal Executive Officer and Principal Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based on that evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in the reports that we file or submit under the Exchange Act reports is (1) recorded, processed, summarized and reported within the periods specified in the Commission’s rules and forms, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Internal control systems, no matter how well designed and operated, have inherent limitations. Therefore, even a system which is determined to be effective cannot provide absolute assurance that all control issues have been detected or prevented. Our systems of internal controls are designed to provide reasonable assurance with respect to financial statement preparation and presentation.

Management will continue to review and make any changes it deems necessary to the overall design of the Company’s internal control over financial reporting, including implementing improvements in policies and procedures. We are committed to a proper internal control environment and will continue to implement measures to improve the Company’s internal control over financial reporting in response to our continued operational development.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter ended ~~June~~September 30, ~~2023~~ 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings

No disclosure required.

Item 1A - Risk Factors

Not required for Smaller Reporting Companies.

Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds

No disclosure required.

Item 3 - Defaults Upon Senior Securities

No disclosure required.

Item 4 – Mine Safety Disclosures

No disclosure required.

Item 5 - Other Information

No disclosure required.

Item 6 - Exhibits

Exhibit No.		Description
31.1*		Certification of Principal Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
31.2*		Certification of Principal Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934.
32.1*		Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*		Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**		Inline XBRL Instance Document.
101.SCH**		Inline XBRL Taxonomy Extension Schema Document.
101.CAL**		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF**		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB**		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE**		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104*		Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended ~~June~~September 30, 2023 is formatted in Inline XBRL

* Filed herewith

** Furnished herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	TEO Foods Inc.
Date: August 21, 2023	By:	/s/ Jeffrey H. Mackay
Date: December 28, 2023	By:	/s/ Jeffrey H. Mackay
		Jeffrey H. Mackay, CEO and President
		Principal Executive Officer

Date: August 21, 2023	By:	/s/ John O’Keefe
Date: December 28, 2023	By:	/s/ John O’Keefe
		John O’Keefe, Chief Financial Officer
		Principal Financial Officer

Filing Compare · TEO FOODS INC